TIFFANY JONES: Open Payments
NPI 1013534494 · PORT ALLEN, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,095 in 80 payments from 16 companies in 2025. Trend: 2023 $1,358 · 2024 $1,074 · 2025 $1,095
Food & beverage: $1,095
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $260 |
| AstraZeneca Pharmaceuticals LP | 7 | $192 |
| Novo Nordisk Inc | 12 | $159 |
| Axsome Therapeutics, Inc. | 3 | $74 |
| Corium, LLC | 4 | $58 |
| Phathom Pharmaceuticals, Inc. | 8 | $48 |
| Esperion Therapeutics, Inc. | 3 | $48 |
| PFIZER INC. | 2 | $45 |
| Lilly USA, LLC | 2 | $44 |
| Amgen Inc. | 2 | $36 |
Products named: AIRSUPRA, VRAYLAR, Rybelsus, Auvelity, UBRELVY, Azstarys, VOQUEZNA, NEXLETOL.
Industry payments across LA — which companies pay providers there.
